Eli Lilly and Company (ETR:LLY)
Germany · Delayed Price · Currency is EUR 926.60
-20.70 (-2.19%)
At close: Nov 28, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€1,077,521
Profits / Employee
€333,886
Market Cap
830.46B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
Eli Lilly and Company News
- 1 day ago - Is Eli Lilly a Millionaire Maker? - The Motley Fool
- 1 day ago - These Are 2 of the Smartest Growth Stocks to Invest $5,000 in Today - The Motley Fool
- 2 days ago - S&P 500 Gains and Losses Today: Intel Soars Amid Apple Deal Rumors; Eli Lilly Stock Slides - Investopedia
- 2 days ago - Don't expect much from Eli Lilly stock anymore, says Len Yaffee - Invezz
- 3 days ago - Prediction: This Growth Stock Could Hit a $2 Trillion Valuation by 2031 - The Motley Fool
- 4 days ago - Stock Split Watch: Is Eli Lilly Next? - The Motley Fool
- 4 days ago - Wall Street Breakfast Podcast: HP Downsizes To Power Up - Seeking Alpha
- 6 days ago - Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium - PRNewsWire